Recurrent and persistent hematuria with diffuse mesangiocapillary glomerulonephritis
ICD-10 N02.5 is a billable code used to indicate a diagnosis of recurrent and persistent hematuria with diffuse mesangiocapillary glomerulonephritis.
N02.5 refers to a condition characterized by recurrent and persistent hematuria, which is the presence of blood in the urine, associated with diffuse mesangiocapillary glomerulonephritis (MCGN). MCGN is a type of kidney disease that affects the glomeruli, the filtering units of the kidneys, leading to inflammation and damage. This condition can result in significant proteinuria, which is the presence of excess protein in the urine, and may progress to nephrotic syndrome, characterized by high levels of proteinuria, low serum albumin, and edema. Patients typically present with symptoms such as hematuria, flank pain, and signs of renal impairment. Renal biopsy findings in MCGN often reveal mesangial proliferation and capillary wall thickening, which are indicative of the underlying pathology. Management of this condition involves addressing the underlying cause, controlling blood pressure, and potentially using immunosuppressive therapy to reduce inflammation and prevent further kidney damage.
Detailed documentation of renal function tests, urinalysis results, and biopsy findings.
Patients presenting with hematuria, proteinuria, and renal impairment.
Ensure that all laboratory results are clearly documented and correlate with clinical findings.
Comprehensive reports on renal biopsy findings, including histological analysis.
Evaluation of renal biopsies for suspected glomerulonephritis.
Pathology reports should clearly indicate the type of glomerular disease and any associated findings.
Used when a renal biopsy is performed to confirm MCGN.
Document indication for biopsy, consent, and findings.
Nephrologists must ensure that the biopsy results correlate with clinical findings.
Hematuria is a key symptom of MCGN, indicating glomerular inflammation and damage. It is essential for diagnosis and monitoring of the disease.
